172 related articles for article (PubMed ID: 17923873)
1. Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer.
Pinzon-Charry A; Ho CS; Maxwell T; McGuckin MA; Schmidt C; Furnival C; Pyke CM; López JA
Br J Cancer; 2007 Nov; 97(9):1251-9. PubMed ID: 17923873
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
Pinzon-Charry A; Maxwell T; McGuckin MA; Schmidt C; Furnival C; López JA
Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648
[TBL] [Abstract][Full Text] [Related]
3. A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer.
Pinzon-Charry A; Ho CS; Laherty R; Maxwell T; Walker D; Gardiner RA; O'Connor L; Pyke C; Schmidt C; Furnival C; López JA
Neoplasia; 2005 Dec; 7(12):1112-22. PubMed ID: 16354594
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation.
Pinzon-Charry A; Maxwell T; Prato S; Furnival C; Schmidt C; López JA
Neoplasia; 2005 Dec; 7(12):1123-32. PubMed ID: 16354595
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings.
Della Porta M; Danova M; Rigolin GM; Brugnatelli S; Rovati B; Tronconi C; Fraulini C; Russo Rossi A; Riccardi A; Castoldi G
Oncology; 2005; 68(2-3):276-84. PubMed ID: 16015045
[TBL] [Abstract][Full Text] [Related]
6. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
[TBL] [Abstract][Full Text] [Related]
7. IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.
Luft T; Jefford M; Luetjens P; Hochrein H; Masterman KA; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
J Immunol; 2002 Jan; 168(2):713-22. PubMed ID: 11777965
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
Eisendle K; Lang A; Eibl B; Nachbaur D; Glassl H; Fiegl M; Thaler J; Gastl G
Br J Haematol; 2003 Jan; 120(1):63-73. PubMed ID: 12492578
[TBL] [Abstract][Full Text] [Related]
9. Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes.
Thomachot MC; Bendriss-Vermare N; Massacrier C; Biota C; Treilleux I; Goddard S; Caux C; Bachelot T; Blay JY; Menetrier-Caux C
Int J Cancer; 2004 Jul; 110(5):710-20. PubMed ID: 15146561
[TBL] [Abstract][Full Text] [Related]
10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
11. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination.
Pedersen AE; Thorn M; Gad M; Walter MR; Johnsen HE; Gaarsdal E; Nikolajsen K; Buus S; Claesson MH; Svane IM
Scand J Immunol; 2005 Feb; 61(2):147-56. PubMed ID: 15683451
[TBL] [Abstract][Full Text] [Related]
13. Generation of dendritic cells ex vivo: differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors.
Syme RM; Duggan P; Stewart D; Glück S
J Hematother Stem Cell Res; 2001 Oct; 10(5):621-30. PubMed ID: 11672508
[TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
15. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
16. Poor yield of dendritic cell precursors from untreated pediatric cancer.
Vakkila J; Vettenranta K; Sariola H; Saarinen-Pihkala UM
J Hematother Stem Cell Res; 2001 Dec; 10(6):787-93. PubMed ID: 11798505
[TBL] [Abstract][Full Text] [Related]
17. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines.
Barratt-Boyes SM; Zimmer MI; Harshyne LA; Meyer EM; Watkins SC; Capuano S; Murphey-Corb M; Falo LD; Donnenberg AD
J Immunol; 2000 Mar; 164(5):2487-95. PubMed ID: 10679086
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
19. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
20. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
Mohty M; Isnardon D; Blaise D; Mozziconacci MJ; Lafage-Pochitaloff M; Brière F; Gastaut JA; Olive D; Gaugler B
Leukemia; 2002 Nov; 16(11):2267-74. PubMed ID: 12399972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
